| SC 13G/A | 2023-02-15 | Western Standard LLC | OPIANT PHARMACEUTICALS, INC. | 424,080 | 8.2% | EDGAR |
| SC 13G | 2022-11-28 | Western Standard LLC | OPIANT PHARMACEUTICALS, INC. | 382,573 | 7.4% | EDGAR |
| SC 13D/A | 2022-06-17 | Sinclair Michael | OPIANT PHARMACEUTICALS, INC. | 515,170 | 9.3% | EDGAR |
| SC 13D/A | 2022-06-17 | CRYSTAL ROGER | OPIANT PHARMACEUTICALS, INC. | 636,594 | 11.2% | EDGAR |
| SC 13G/A | 2022-02-10 | RENAISSANCE TECHNOLOGIES LLC | OPIANT PHARMACEUTICALS, INC. | 183,815 | 3.9% | EDGAR |
| SC 13G/A | 2022-01-27 | WELLS FARGO & COMPANY/MN | OPIANT PHARMACEUTICALS, INC. | 224,297 | 4.8% | EDGAR |
| SC 13G/A | 2021-02-16 | Radoff Bradley Louis | OPIANT PHARMACEUTICALS, INC. | 13,000 | 0.0% | EDGAR |
| SC 13G/A | 2021-02-12 | Stonepine Capital Management, LLC | OPIANT PHARMACEUTICALS, INC. | 0 | 0.0% | EDGAR |
| SC 13G/A | 2021-02-11 | Altium Capital Management LP | OPIANT PHARMACEUTICALS, INC. | 0 | 0.0% | EDGAR |
| SC 13G | 2021-02-11 | WELLS FARGO & COMPANY/MN | OPIANT PHARMACEUTICALS, INC. | 252,205 | 5.9% | EDGAR |
| SC 13G | 2021-02-10 | RENAISSANCE TECHNOLOGIES LLC | OPIANT PHARMACEUTICALS, INC. | 236,815 | 5.6% | EDGAR |
| SC 13G/A | 2020-02-14 | Radoff Bradley Louis | OPIANT PHARMACEUTICALS, INC. | 264,900 | 6.5% | EDGAR |
| SC 13G/A | 2020-02-14 | Altium Capital Management LP | OPIANT PHARMACEUTICALS, INC. | 349,846 | 8.5% | EDGAR |
| SC 13G/A | 2020-02-13 | Stonepine Capital Management, LLC | OPIANT PHARMACEUTICALS, INC. | 334,272 | 8.2% | EDGAR |
| SC 13D/A | 2020-02-06 | OPIANT PHARMACEUTICALS, INC. | OPIANT PHARMACEUTICALS, INC. | 715,170 | 15.0% | EDGAR |
| SC 13D/A | 2020-02-06 | OPIANT PHARMACEUTICALS, INC. | OPIANT PHARMACEUTICALS, INC. | 587,325 | 12.3% | EDGAR |
| SC 13G | 2019-07-08 | Radoff Bradley Louis | OPIANT PHARMACEUTICALS, INC. | 255,000 | 6.4% | EDGAR |
| SC 13G | 2019-06-05 | Altium Capital Management LP | OPIANT PHARMACEUTICALS, INC. | 252,873 | 6.3% | EDGAR |
| SC 13G/A | 2019-02-13 | Stonepine Capital Management, LLC | OPIANT PHARMACEUTICALS, INC. | 357,960 | 9.3% | EDGAR |
| SC 13D/A | 2018-10-09 | Pollack Kevin | OPIANT PHARMACEUTICALS, INC. | 148,834 | 5.0% | EDGAR |